Prevention of cataract in diabetic mice by topical pyruvate

Clinical Ophthalmology

Volumn 5, Issue 1, 2011, Pages 1141-1145

  Hegde, K R ^a,b   Kovtun, S ^a   Varma, S D ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b PA   (United States)

Author keywords

Diabetic cataract; Oxidative stress; Protein glycation; Pyruvate eye drops

Indexed keywords

EYE DROPS; GLUTATHIONE; PYRUVATE SODIUM; STREPTOZOCIN; TROPICAMIDE;

ANIMAL EUTHANASIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CATARACT; CHEMICAL ANALYSIS; CONTINUOUS INFUSION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFICACY; ENUCLEATION; INCIDENCE; MOUSE; MYDRIASIS; NONHUMAN; OPHTHALMOSCOPY; PROTEIN GLYCOSYLATION; PROTEIN SYNTHESIS INHIBITION; STREPTOZOCIN DIABETES;

EID: 80051742584     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Resnikoff S, Pascolini D, Etya'ale D, et al. Global data on visual impairment in the year 2002. Bull World Health Organ. 2004;82:844-851.
2. Varma SD, Srivastava VK, Richards RD. Photoperoxidation in lens and cataract formation: preventive role of superoxide dismutase, catalase and vitamin C. Ophthalmic Res. 1982;14:167-175.
3. Spector A, Garner WH. Hydrogen peroxide and human cataract. Exp Eye Res. 1981;33:673-681.
4. Varma SD, Ets TK, Richards RD. Protection against superoxide radicals in rat lens. Ophthalmic Res. 1977;9:421-431.
5. Bhuyan DK, Bhuyan KC. Regulation of hydrogen peroxide in eye humors. Effect of 3-amino-1H-1,2,4-triazole on catalase and glutathione peroxidase of rabbit eye. Biochim Biophys Acta. 1977;497:641-651.
6. Van Heyningen R. Photo-oxidation of lens proteins by sun light in the presence of derivatives of kynurenine isolated from human lens. Exp Eye Res. 1973;17:137-147.
7. Dillon J, Wang RH, Athertso S. Photo-chemical and photo-physical studies on human lens constituents. Photochem Photobiol. 1990;2: 849-854.
8. Harding JJ, Egerton M, van Heyningen R, Harding RS. Diabetes, glaucoma, sex, and cataract: analysis of combined data from two case control studies. Br J Ophthalmol. 1993;77:2-6.
9. Kahn HA, Leibowitz HM, Ganley JP, et al. The Framingham eye study. Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am J Epidemiol. 1977; 106:33-41.
10. Rowe N, Mitchell P, Cumming RG, Wans JJ. Diabetes, fasting blood glucose and age-related cataract: the Blue Mountains Eye Study. Ophthalmic Epidemiol. 2000;7:103-114.
11. Wolff SP, Crabbe MJC, Thornalley PJ. The autooxidation of glyceraldehydes and other simple monosaccharides. Experientia. 1984;40: 244-246.
12. Stevens MJ, Rouzer CA, Monnier VM, Cerami A. Diabetic cataract formation and potential role of glycosylation of lens proteins. Proc Natl Acad Sci U S A. 1978;75:2918-2922.
13. Baynes JW. Role of oxidative stress in development of complications in diabetes. Diabetes. 1991;40:405-412.
14. Richardson HB, Levine SZ. Clinical calorimetry. Exercise and the respiratory quotient in diabetes. J Biol Chem. 39;66:161-183.
15. Kobatashi S, Roy D, Spector A. Sodium/potassium ATPase in normal and cataractous human lenses. Curr Eye Res. 1982;2:327-334.
16. Varma SD, Morris SM. Peroxide damage to the eye lens in vitro: prevention by pyruvate. Free Radic Res Comm. 1988;4:283-290.
17. Devamanoharan PLS, Henein M, Morris SM, Ramachandran S, Richards RD, Varma SD. Prevention of selenite cataract by vitamin C. Exp Eye Res. 1991;52:563-568.
18. Ross WM, Creighton MOP, Stewart-DeHaan PJ, Sanwal M, Hirst M, Trevithick JR. Modelling cortical cataractogenesis. 3. In vivo effects of vitamin E on cataractogenesis in diabetic rats. Can J Ophthalmol. 1982;17:61-66.
19. Nagaraj RH, Monnier VM. Protein modification by the degradation products of ascorbate: formation of a novel pyrrole from the Maillard reaction of L-threose with proteins. Biochim Biophys Acta. 1995;1253: 75-84.
20. Zhao W, Devamanoharan PS, Henein M, Ali AH, Varma SD. Diabetes induced biochemical changes in rat lens: attenuation of cataractogenesis by pyruvate. Diabetes Obes Metab. 2000;2:165-174.
21. Hegde KR, Varma SD. Prevention of cataract by pyruvate in experimentally diabetic mice. Mol Cell Biochem. 2005;269:115-120.
22. Varma SD, Kinoshita JH. The absence of cataracts in mice with congenital hyperglycemia. Exp Eye Res. 1974;19:577-582.
23. Hegde KR, Varma SD. Morphogenetic and apoptotic changes in diabetic cataract: prevention by pyruvate. Mol Cell Biochem. 2004;262: 233-237.
24. Hegde KR, Kovtun S, Varma SD. Intraocular penetration of pyruvate following its topical administration in mice. Mol Cell Biochem. 2010;338:87-90.
25. Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys. 1959;82: 70-77.
26. Chandra P, Hegde KR, Varma SD. Possibility of topical antioxidant treatment of cataracts: corneal penetration of pyruvate in humans. Ophthalmologica. 2009;223:136-138.
27. Ervens B, Gligorovski S, Herrmann H. Temperature dependent rate constants for hydroxyl radical reactions with organic compounds in aqueous solutions. Phys Chem Chem Phys. 2003;5:1811-1824.
28. Millouki A, Mu YJ. On atmospheric degradation of pyruvic acid in the gas phase. J Photchem Photobiol A Chem. 2003;157:295-300.